Compare Novartis AG (NVS) vs Ryanair Holdings plc (RYAAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Ryanair Holdings plc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Ryanair Holdings plc trades at $58.99 (market cap $29.31B). The key difference: Novartis AG is far larger — about 9.9× Ryanair Holdings plc's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.
| NVS | RYAAY | |
|---|---|---|
Market Cap | $290.25B | $29.31B |
Sector | Health | Industrials |
52-Week High | $168.62 | $73.82 |
52-Week Low | $113.50 | $53.24 |
Enterprise Value | $330.27B | $26.33B |
Dividend Yield | 3.17% | 1.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Ryanair Holdings plc
Ryanair is the leading airline group by passenger numbers in Europe. The company employs a low-cost no-frills model to offer low fares to leisure customers on short-haul intra-European routes. In 2020, the most recent pre-pandemic fiscal year, the company carried 149 million passengers, utilizing a fleet of 467 Boeing 737 aircraft across its 1,800 routes. To keep costs low the company serves predominantly lower-cost secondary airports. The company generated sales of EUR 8.5 billion in fiscal 2020.
Read more on RYAAY →
